Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 4:03 pm Sale | 13G | TITAN MED INC TMDI | Anson Funds Management LP | 1,814,089 4.9% | -816,745 (-31.05%) | View |
2020-02-14 3:56 pm Sale | 13G | DELMAR PHARMACEUTICALS INC DMPI | Anson Funds Management LP | 290,125 1.5% | -4,875 (-1.65%) | View |
2020-02-14 3:52 pm Purchase | 13G | CERVOMED INC CRVO | Anson Funds Management LP | 640,270 1.6% | 201,250 (+45.84%) | View |
2019-12-06 09:46 am Sale | 13G | GREENLANE HLDGS INC GNLN | Anson Funds Management LP | 139,951 1.4% | -1,289,543 (-90.21%) | View |
2019-09-30 06:14 am Purchase | 13G | AIM IMMUNOTECH INC AIM | Anson Funds Management LP | 1,277,222 9.9% | 1,277,222 (New Position) | View |
2019-09-27 11:18 am Purchase | 13G | PLUS THERAPEUTICS INC PSTV | Anson Funds Management LP | 369,379 9.9% | 369,379 (New Position) | View |
2019-09-24 11:25 am Purchase | 13G | GREENLANE HLDGS INC GNLN | Anson Funds Management LP | 1,429,494 14.3% | 1,429,494 (New Position) | View |
2019-09-11 1:18 pm Purchase | 13G | ARCADIA BIOSCIENCES INC NE RKDA | Anson Funds Management LP | 529,340 6.1% | 529,340 (New Position) | View |
2019-08-14 5:46 pm Purchase | 13G | SOCIAL REALITY INC NE SRAX | Anson Funds Management LP | 1,437,995 9.9% | 1,437,995 (New Position) | View |
2019-08-02 08:53 am Purchase | 13G | SAFE T GROUP LTD SFET | Anson Funds Management LP | 16,041,520 6.6% | 13,307,725 (+486.79%) | View |
2019-07-29 06:10 am Purchase | 13G | XENETIC BIOSCIENCES INC PA XBIO | Anson Funds Management LP | 260,000 9.8% | 260,000 (New Position) | View |
2019-07-12 08:41 am Purchase | 13G | LEAFBUYER TECHNOLOGI LBUY | Anson Funds Management LP | 3,605,769 6.6% | 3,605,769 (New Position) | View |
2019-06-28 08:43 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | Anson Funds Management LP | 359,907 9.9% | 359,907 (New Position) | View |
2019-06-24 4:22 pm Purchase | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Anson Funds Management LP | 5,000,000 9.7% | 5,000,000 (New Position) | View |
2019-06-13 4:08 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | Anson Funds Management LP | 295,000 7.7% | 295,000 (New Position) | View |
2019-06-03 08:39 am Purchase | 13G | CERVOMED INC CRVO | Anson Funds Management LP | 439,020 9.4% | 439,020 (New Position) | View |
2019-05-28 3:58 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Anson Funds Management LP | 600,000 6.4% | 600,000 (New Position) | View |
2019-05-20 4:22 pm Purchase | 13G | SEANERGY MARITIME HLDGS COPR S SHIP | Anson Funds Management LP | 557,627 9.9% | 557,627 (New Position) | View |